Literature DB >> 12502840

Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.

Stefan F Wieland1, Raquel G Vega, Rolf Müller, Claire F Evans, Brian Hilbush, Luca G Guidotti, J Gregor Sutcliffe, Peter G Schultz, Francis V Chisari.   

Abstract

We have previously shown that alpha/beta interferon (IFN-alpha/beta) and IFN-gamma inhibit hepatitis B virus (HBV) replication noncytopathically in the livers of HBV transgenic mice and in hepatocyte cell lines derived from these mice. The present study was designed to identify transcriptionally controlled hepatocellular genes that are tightly associated with the inhibition of HBV replication and that might, therefore, mediate the antiviral effect of these cytokines. Twenty-nine genes were identified, many of which have known or potential antiviral activity. Notably, multiple components of the immunoproteasome and ubiquitin-like proteins were strongly induced by both IFN-alpha/beta and IFN-gamma, as were a number of GTP-binding proteins, including GTPases with known antiviral activity, chemokines, signaling molecules, and miscellaneous genes associated with antigen processing, DNA-binding, or cochaperone activity and several expressed sequence tags. The results suggest that one or more members of this relatively small subset of genes may mediate the antiviral effect of IFN-alpha/beta and IFN-gamma against HBV. We have already exploited this information by demonstrating that the antiviral activity of IFN-alpha/beta and IFN-gamma is proteasome dependent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502840      PMCID: PMC140855          DOI: 10.1128/jvi.77.2.1227-1236.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP.

Authors:  G A Taylor; C M Collazo; G S Yap; K Nguyen; T A Gregorio; L S Taylor; B Eagleson; L Secrest; E A Southon; S W Reid; L Tessarollo; M Bray; D W McVicar; K L Komschlies; H A Young; C A Biron; A Sher; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.

Authors:  T Moriyama; S Guilhot; K Klopchin; B Moss; C A Pinkert; R D Palmiter; R L Brinster; O Kanagawa; F V Chisari
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

3.  Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein.

Authors:  J Pavlovic; T Zürcher; O Haller; P Staeheli
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines.

Authors:  A Simon; J Fäh; O Haller; P Staeheli
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

5.  The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro.

Authors:  M Groettrup; T Ruppert; L Kuehn; M Seeger; S Standera; U Koszinowski; P M Kloetzel
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

6.  The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins.

Authors:  K R Loeb; A L Haas
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

7.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.

Authors:  B Samal; Y Sun; G Stearns; C Xie; S Suggs; I McNiece
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  High-level hepatitis B virus replication in transgenic mice.

Authors:  L G Guidotti; B Matzke; H Schaller; F V Chisari
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3.

Authors:  D E Levy; D J Lew; T Decker; D S Kessler; J E Darnell
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.

Authors:  A J Sijts; T Ruppert; B Rehermann; M Schmidt; U Koszinowski; P M Kloetzel
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  49 in total

1.  A PKR-like eukaryotic initiation factor 2alpha kinase from zebrafish contains Z-DNA binding domains instead of dsRNA binding domains.

Authors:  Stefan Rothenburg; Nikolaus Deigendesch; Katharina Dittmar; Friedrich Koch-Nolte; Friedrich Haag; Ky Lowenhaupt; Alexander Rich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

Review 2.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Rapid upregulation of interferon-regulated and chemokine mRNAs upon injection of 108 international units, but not lower doses, of adenoviral vectors into the brain.

Authors:  Jeffrey M Zirger; Carlos Barcia; Chunyan Liu; Mariana Puntel; Ngan Mitchell; Iain Campbell; Maria Castro; Pedro R Lowenstein
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment.

Authors:  Shi-He Guan; Mengji Lu; Petra Grünewald; Michael Roggendorf; Guido Gerken; Jörg F Schlaak
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

5.  Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.

Authors:  Chuan-Long Zhu; Wei-Ming Yan; Fan Zhu; Yong-Fen Zhu; Dong Xi; De-Ying Tian; Gary Levy; Xiao-Ping Luo; Qin Ning
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

6.  Establishment and primary application of a mouse model with hepatitis B virus replication.

Authors:  Feng-Jun Liu; Li Liu; Fang He; Su Wang; Tao-You Zhou; Cong Liu; Lin-Yu Deng; Hong Tang
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

7.  Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus.

Authors:  Michael D Robek; Mayra L Garcia; Bryan S Boyd; Francis V Chisari
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner.

Authors:  Zhensheng Zhang; Ulrike Protzer; Zongyi Hu; James Jacob; T Jake Liang
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Genomic analysis of the host response to hepatitis B virus infection.

Authors:  Stefan Wieland; Robert Thimme; Robert H Purcell; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

10.  Bortezomib inhibits hepatitis B virus replication in transgenic mice.

Authors:  Prasanthi Bandi; Mayra L Garcia; Carmen J Booth; Francis V Chisari; Michael D Robek
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.